August 31, 2016 12:27 PM ET

Biotechnology

Company Overview of Capricor Therapeutics, Inc.

Executive Profile

Earl M. Collier Jr., J.D., Esq.

Director and Chairman of Nominating & Corporate Governance Committee, Capricor Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 Board Members in 9 different organizations across 16 different industries.

See Board Relationships
69$27,877

Background

Mr. Earl M. Collier Jr., also known as Duke, J.D., Esq., served as the Chief Executive Officer at 480 Biomedical, Inc. served from 2010 to 2014. Mr. Collier served as Part-Time Senior Advisor at Genzyme Corporation since October 2009 and served as its Executive Vice President from July 1997 to October 2009. He has more than 30 years of experience in healthcare. He served as Senior Advisor at Polaris Partners. He served as the Chief Executive Officer and Executive Chairman ...

Corporate Headquarters

8840 Wilshire Boulevard
Beverly Hills, California 90211

United States

Phone: 310-358-3200
Fax: --

Board Members Memberships

Director
Director
Chairman
Director
Director
2011-Present
Director and Chairman of Nominating & Corporate Governance Committee
2014-Present
Independent Director, Chairman of Governance & Nominating Committee and Member of Compensation Committee

Education

BA
Yale University
JD
University of Virginia School of Law

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Calculated Compensation$27,877
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robin C. Stracey Chief Executive Officer, President and Director
Cesca Therapeutics Inc.
$283.0K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$450.0K
David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Caladrius Biosciences, Inc.
$541.4K
Mike Tomas Chief Executive Officer, President, Chief Financial Officer and Director
U.S. Stem Cell, Inc.
$660.5K
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$465.3K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Capricor Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.